# Nivestym

NDC: 0069-0293
Generic name: filgrastim-aafi
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20190311

FDA application: BLA761080

## Active ingredients

- FILGRASTIM: 300 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0293"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0293
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d23ab39c-b6ec-41cf-a529-9dd2852c9d9a